Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Switzerland Tech Review.
Press releases published on April 30, 2025
OPIC Technologies, Inc. Introduces Spatial Live Streaming for Medical Training and Education
EIN Presswire
·
April 30, 2025
OPIC’s Spatial Live Stream tech offers depth-rich views of surgeries and anatomy, enhancing medical training with greater realism and precision. ORLANDO , FL, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- OPIC Technologies, Inc., the global …
Mobile Payment Transaction Market to Reach USD 60.8 Trillion by 2035, Growing at a CAGR of 13.2%
EIN Presswire
·
April 30, 2025
The Mobile Payment Transaction Market focuses on the growth, trends, and adoption of digital payment solutions through smartphones and mobile devices. NEWARK, DE, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- The mobile payment transaction market …
Wearable Computing Devices Market to Soar to USD 235.7 Billion by 2035, Recording a 10.2% CAGR
EIN Presswire
·
April 30, 2025
The Wearable Computing Devices Market covers trends, innovations, and applications of smart wearable tech across health, fitness, communication, and more. NEWARK, DE, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- The wearable computing devices …
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
April 30, 2025
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update Continuing to advance clinical active immunotherapy portfolio for precision prevention of neurodegenerative diseases Positive immunogenicity and good safety in interim …
RetinAI and FVS Announce CE-MDR Certification for Co-developed AI-based Diabetic Retinopathy Screening Algorithm, LuxIA®
GlobeNewswire
·
April 30, 2025
BERN, Switzerland and MADRID, April 30, 2025 (GLOBE NEWSWIRE) -- RetinAI US Inc. (RetinAI) and Fundación Ver Salud (FVS) are pleased to jointly announce that LuxIA®, their co-developed innovative AI algorithm for Diabetic Retinopathy (DR) screening, has …
Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery
GlobeNewswire
·
April 30, 2025
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 30, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for …